Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2020

01-08-2020 | Research Article

Self-reported clinical pharmacy service provision in Austria: an analysis of both the community and hospital pharmacy sector—a national study

Authors: S. Deibl, D. Mueller, K. Kirchdorfer, G. Stemer, M. Hoppel, A. E. Weidmann

Published in: International Journal of Clinical Pharmacy | Issue 4/2020

Login to get access

Abstract

Background With expansion of more advanced clinical roles for pharmacists we need to be mindful that the extent to which clinical pharmacy services are implemented varies from one country to another. To date no comprehensive assessment of number and types of services provided by either community or hospital pharmacies in Austria exists. Objective To analyse and describe the number and types of clinical pharmacy services provided in both community and hospital pharmacies, as well as the level of clinical pharmacy education of pharmacists across Austria. Setting Austrian community and hospital pharmacies. Method An electronic questionnaire to determine number and types of clinical pharmacy services provided was send to all chief pharmacists at all community (n = 1365) and hospital pharmacies (n = 40) across Austria. Besides current and future services provision, education and training provision were also assessed. Main outcome measure Extent of and attitude towards CPS in Austria. Results Response rates to the surveys were 19.1% (n = 261/1365) in community and 92.5% (n = 37/40) in hospital pharmacies. 59.0% and 89.2% of community and hospital pharmacies, respectively, indicated that the provision of clinical pharmacy services in Austria has increased substantially over the past 10 years. Fifty-one percent of community pharmacies reported to provide a medication review service, while 97.3% of hospitals provide a range of services. Only 18.0% of community pharmacies offer services other than medication review services at dispensing. Binary regressions show that provision of already established medication management is a predictor for the willingness of community pharmacists to extend the range of CPS (p < 0.01), while completed training in the area of clinical pharmacy is not (p > 0.05). More hospital than community pharmacists have postgraduate education in clinical pharmacy (17.4% vs 6.5%). A desire to complete postgraduate education was shown by 28.3% of community and 14.7% of hospital pharmacists. Lack of time, inadequate remuneration, lack of resources and poor relationship between pharmacists and physicians were highlighted as barriers. Conclusion Both community and hospital pharmacists show strong willingness to expand their service provision and will need continued support, such as improved legislative structures, more supportive resources and practice focused training opportunities, to further these services.
Appendix
Available only for authorised users
Literature
2.
go back to reference LeBlanc JM, Seoane-Vazquez E, Dasta JF. Survey of hospital pharmacist activities outside of the United States. Am J Health Syst Pharm. 2007;64(16):1748–55.CrossRef LeBlanc JM, Seoane-Vazquez E, Dasta JF. Survey of hospital pharmacist activities outside of the United States. Am J Health Syst Pharm. 2007;64(16):1748–55.CrossRef
3.
go back to reference Gums J. Changing the direction of clinical pharmacy outside the united states: time to step up. Pharmacother. 2013;33(2):122–5.CrossRef Gums J. Changing the direction of clinical pharmacy outside the united states: time to step up. Pharmacother. 2013;33(2):122–5.CrossRef
4.
go back to reference Bulajeva A, Labberton L, Leikola S, Pohjanoksa-Mäntylä M, Geurts MME, de Gier JJ, Airaksinen M. Medication review practices in European countries. Res Social Adm Pharm. 2014;10:731–40.CrossRef Bulajeva A, Labberton L, Leikola S, Pohjanoksa-Mäntylä M, Geurts MME, de Gier JJ, Airaksinen M. Medication review practices in European countries. Res Social Adm Pharm. 2014;10:731–40.CrossRef
6.
go back to reference Rose O, Derendorf H, Erzkamp S, Fujita K, Hartl A, Hoti K, et al. Development of clinical pharmacy services in Australia, Austria, Belgium, Bosnia Herzegovina, Canada, Germany, Japan, Kosovo, Switzerland, the Netherlands, Thailand, USA and correlation with educational standards, level of research, and implementation practices. Int J Clin Pharmacol Ther. 2018. https://doi.org/10.5414/CP203264.CrossRefPubMed Rose O, Derendorf H, Erzkamp S, Fujita K, Hartl A, Hoti K, et al. Development of clinical pharmacy services in Australia, Austria, Belgium, Bosnia Herzegovina, Canada, Germany, Japan, Kosovo, Switzerland, the Netherlands, Thailand, USA and correlation with educational standards, level of research, and implementation practices. Int J Clin Pharmacol Ther. 2018. https://​doi.​org/​10.​5414/​CP203264.CrossRefPubMed
7.
go back to reference Bladh L, Ottosson E, Karlsson J, Klintberg L, Wallerstedt SM. Effects of a clinical pharmacist service on health-related quality of life and prescribing of drugs: a randomised controlled trial. BMJ Qual Saf. 2011;20(9):738–46.CrossRef Bladh L, Ottosson E, Karlsson J, Klintberg L, Wallerstedt SM. Effects of a clinical pharmacist service on health-related quality of life and prescribing of drugs: a randomised controlled trial. BMJ Qual Saf. 2011;20(9):738–46.CrossRef
8.
go back to reference Bond CA, Raehl CL. 2006 national clinical pharmacy services survey: clinical pharmacy services, collaborative drug management, medication errors, and pharmacy technology. Pharmacother. 2008;28(1):1–13.CrossRef Bond CA, Raehl CL. 2006 national clinical pharmacy services survey: clinical pharmacy services, collaborative drug management, medication errors, and pharmacy technology. Pharmacother. 2008;28(1):1–13.CrossRef
9.
go back to reference Bunting B, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc. 2006;46(2):133–47.CrossRef Bunting B, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc. 2006;46(2):133–47.CrossRef
10.
go back to reference Bunting BA, Smith BH, Sutherland SE. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc. 2008;48(1):23–31.CrossRef Bunting BA, Smith BH, Sutherland SE. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc. 2008;48(1):23–31.CrossRef
11.
go back to reference Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43(2):173–84. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43(2):173–84.
15.
go back to reference Westerlund T, Marklund B. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems. J Clin Pharm Ther. 2009;34(3):319–27.CrossRef Westerlund T, Marklund B. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems. J Clin Pharm Ther. 2009;34(3):319–27.CrossRef
16.
go back to reference Hadi MA, Alldred DP, Briggs M, Munyombwe T, Closs SJ. Effectiveness of pharmacist-led medication review in chronic pain management: systematic review and meta-analysis. Clin J Pain. 2014;30(11):1006–144.CrossRef Hadi MA, Alldred DP, Briggs M, Munyombwe T, Closs SJ. Effectiveness of pharmacist-led medication review in chronic pain management: systematic review and meta-analysis. Clin J Pain. 2014;30(11):1006–144.CrossRef
17.
go back to reference Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296(21):2563–71.CrossRef Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296(21):2563–71.CrossRef
18.
go back to reference Stemer G, Laml-Wallner G, Kuegler I, Poelzleitner P, Messner S, Steininger S et al. Comprehensive evaluation of clinical pharmacists’ interventions in a large Austrian tertiary care hospital. Eur J Hosp Pharm Sci Pract. 2012;19:529–34.CrossRef Stemer G, Laml-Wallner G, Kuegler I, Poelzleitner P, Messner S, Steininger S et al. Comprehensive evaluation of clinical pharmacists’ interventions in a large Austrian tertiary care hospital. Eur J Hosp Pharm Sci Pract. 2012;19:529–34.CrossRef
19.
go back to reference Pharmacists ACO. Apotheke in Zahlen 2018. Vienna: Österreichische Apothekerkammer; 2018. Pharmacists ACO. Apotheke in Zahlen 2018. Vienna: Österreichische Apothekerkammer; 2018.
21.
go back to reference Morak S, Vogler S, Walser S, Kijlstra N. Understanding the pharmaceutical care concept and applying it in practice. Vienna: Austrian Federal Ministry of Health; 2010. Morak S, Vogler S, Walser S, Kijlstra N. Understanding the pharmaceutical care concept and applying it in practice. Vienna: Austrian Federal Ministry of Health; 2010.
24.
go back to reference Frontini R, Miharija-Gala T, Sykora J. EAHP Survey 2010 on hospital pharmacy in Europe: Part 1 General frame and staffing. Eur J Hosp Pharm. 2012;19:385–7.CrossRef Frontini R, Miharija-Gala T, Sykora J. EAHP Survey 2010 on hospital pharmacy in Europe: Part 1 General frame and staffing. Eur J Hosp Pharm. 2012;19:385–7.CrossRef
25.
go back to reference Frontini R, Miharija-Gala T, Sykora J. EAHP Survey 2010 on hospital pharmacy in Europe: parts 4 and 5. Clinical services and patient safety. Eur J Hosp Pharm. 2013;20:69–73.CrossRef Frontini R, Miharija-Gala T, Sykora J. EAHP Survey 2010 on hospital pharmacy in Europe: parts 4 and 5. Clinical services and patient safety. Eur J Hosp Pharm. 2013;20:69–73.CrossRef
28.
go back to reference Hsieh HE, Shannon SE. Three Approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88.CrossRef Hsieh HE, Shannon SE. Three Approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88.CrossRef
29.
go back to reference Allenet B, Bedouch P, Rose FX, Escofier L, Roubille R, Charpiat B et al. Validation of an instrument for the documentation of clinical pharmacists' interventions. Pharm World Sci. 2006;28(4):181–8.CrossRef Allenet B, Bedouch P, Rose FX, Escofier L, Roubille R, Charpiat B et al. Validation of an instrument for the documentation of clinical pharmacists' interventions. Pharm World Sci. 2006;28(4):181–8.CrossRef
31.
go back to reference Martins SF, van Mil JWF, da Costa FA. The organizational framework of community pharmacies in Europe. Int J Clin Pharm. 2015;37:896–905.CrossRef Martins SF, van Mil JWF, da Costa FA. The organizational framework of community pharmacies in Europe. Int J Clin Pharm. 2015;37:896–905.CrossRef
32.
go back to reference van Mil JWF, de Boer WO, Tromp THFJ. European barriers to the implementation of pharmaceutical care. Int J Clin Pharm. 2001;9:163–8. van Mil JWF, de Boer WO, Tromp THFJ. European barriers to the implementation of pharmaceutical care. Int J Clin Pharm. 2001;9:163–8.
36.
go back to reference Marquis J, Schneider MP, Spencer B, Bugnon O, Du Pasquier S. Exploring the implementation of a medication adherence programme by community pharmacists: a qualitative study. Int J Clin Pharm. 2014;36(5):1014–22.CrossRef Marquis J, Schneider MP, Spencer B, Bugnon O, Du Pasquier S. Exploring the implementation of a medication adherence programme by community pharmacists: a qualitative study. Int J Clin Pharm. 2014;36(5):1014–22.CrossRef
37.
go back to reference Niquille A, Lattmann C, Bugnon O. Medication reviews led by community pharmacists in Switzerland: a qualitative survey to evaluate barriers and facilitators. Pharm Pract. 2010;8(1):35–42. Niquille A, Lattmann C, Bugnon O. Medication reviews led by community pharmacists in Switzerland: a qualitative survey to evaluate barriers and facilitators. Pharm Pract. 2010;8(1):35–42.
38.
go back to reference Berbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills C. Enhanced pharmacy services, barriers and facilitators in Australia’s community pharmacies: Australia’s National Pharmacy Database Project. Int J Pharm Pract. 2007;15:185–91.CrossRef Berbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills C. Enhanced pharmacy services, barriers and facilitators in Australia’s community pharmacies: Australia’s National Pharmacy Database Project. Int J Pharm Pract. 2007;15:185–91.CrossRef
39.
go back to reference American College Of Clinical Pharmacy Clinical Practice Affairs Committee. Clinical pharmacy practice in the noninstitutional setting A white paper from the American College of Clinical Pharmacy. Pharmacother. 1992;12(4):358–64. American College Of Clinical Pharmacy Clinical Practice Affairs Committee. Clinical pharmacy practice in the noninstitutional setting A white paper from the American College of Clinical Pharmacy. Pharmacother. 1992;12(4):358–64.
40.
go back to reference Doucette WR, Nevis J, Randal C, McDonough PR. Factor affecting collaborative care between pharmacists and physicians. Pharm. 2005;1(4):565–78. Doucette WR, Nevis J, Randal C, McDonough PR. Factor affecting collaborative care between pharmacists and physicians. Pharm. 2005;1(4):565–78.
41.
go back to reference McDonough RP, Doucette WR. Developing collaborative working relationships between pharmacists and physicians. J Am Pharm Assoc. 2001;41(55):682–92. McDonough RP, Doucette WR. Developing collaborative working relationships between pharmacists and physicians. J Am Pharm Assoc. 2001;41(55):682–92.
Metadata
Title
Self-reported clinical pharmacy service provision in Austria: an analysis of both the community and hospital pharmacy sector—a national study
Authors
S. Deibl
D. Mueller
K. Kirchdorfer
G. Stemer
M. Hoppel
A. E. Weidmann
Publication date
01-08-2020
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 4/2020
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-01066-5

Other articles of this Issue 4/2020

International Journal of Clinical Pharmacy 4/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.